The cortisol awakening response in treatment-resistant depression is not a biomarker of the clinical response to ketamine

被引：1
|
作者：
Naughton, M. [1 ]
Allen, A. P. [1 ,2 ]
Clarke, G. [1 ,2 ]
Dowling, J. [3 ]
Walsh, A. [3 ]
Ismail, F. [1 ]
Shorten, G. [3 ]
Scott, L. [1 ]
Cryan, J. F. [2 ,4 ]
Dinan, T. G. [1 ,2 ]
机构：
[1] Natl Univ Ireland Univ Coll Cork, Dept Psychiat, Cork, Ireland
[2] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland
[3] Natl Univ Ireland Univ Coll Cork, Dept Anaesthesia & Intens Care Med, Cork, Ireland
[4] Natl Univ Ireland Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2014年 / 24卷
关键词：
D O I：
10.1016/S0924-977X(14)70639-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.b.038
引用
收藏
页码：S401 / S401
页数：1
相关论文
共 50 条
  • [21] Features of dissociation differentially predict antidepressant response to ketamine in treatment-resistant depression
    Niciu, Mark J.
    Shovestul, Bridget J.
    Jaso, Brittany A.
    Farmer, Cristan
    Luckenbaugh, David A.
    Brutsche, Nancy E.
    Park, Lawrence T.
    Ballard, Elizabeth D.
    Zarat, Carlos A., Jr.
    JOURNAL OF AFFECTIVE DISORDERS, 2018, 232 : 310 - 315
  • [22] Functional Connectivity and Response to Ketamine Therapy in Treatment-Resistant Depression: A Pilot Study
    Vasavada, Megha
    Leaver, Amber
    Loureiro, Joana
    Espinoza, Randall
    Joshi, Shantanu
    Njau, Stephanie
    Wade, Benjamin
    Kubicki, Antoni
    Congdon, Eliza
    Narr, Katherine
    BIOLOGICAL PSYCHIATRY, 2018, 83 (09) : S292 - S292
  • [23] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    Murrough, James W.
    Wan, Le-Ben
    Iacoviello, Brian
    Collins, Katherine A.
    Solon, Carly
    Glicksberg, Benjamin
    Perez, Andrew M.
    Mathew, Sanjay J.
    Charney, Dennis S.
    Iosifescu, Dan V.
    Burdick, Katherine E.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 481 - 488
  • [24] A RESPONSE TO COMMENTARIES ON TREATMENT-RESISTANT DEPRESSION
    MALIZIA, AL
    BRIDGES, PK
    JOURNAL OF PSYCHOPHARMACOLOGY, 1992, 6 (02) : 172 - 175
  • [25] Clinical Predictors of Placebo Response in Treatment-Resistant Major Depression
    Yazdian, Aaron L.
    Park, Lawrence
    Luckenbaugh, David A.
    Niciu, Mark J.
    Lener, Marc
    Nugent, Allison C.
    Ballard, Elizabeth D.
    Brutsche, Nancy E.
    Zarate, Carlos A.
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 260S - 260S
  • [26] Intranasal Ketamine in Treatment-resistant Depression
    Lapidus, Kyle A.
    Levitch, Cara F.
    Soleimani, Laili
    Perez, Andrew M.
    Brallier, Jess W.
    Parides, Michael K.
    Iosifescu, Dan V.
    Charney, Dennis S.
    Murrough, James W.
    NEUROPSYCHOPHARMACOLOGY, 2013, 38 : S361 - S361
  • [27] Oral ketamine for treatment-resistant depression
    Kang, Seema
    LANCET PSYCHIATRY, 2018, 5 (11): : 877 - 877
  • [28] Esketamine/ketamine for treatment-resistant depression
    Lacerda, Acioly L. T.
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2020, 42 (06) : 579 - 580
  • [29] Altered peripheral immune profiles in treatment-resistant depression: response to ketamine and prediction of treatment outcome
    D D Kiraly
    S R Horn
    N T Van Dam
    S Costi
    J Schwartz
    S Kim-Schulze
    M Patel
    G E Hodes
    S J Russo
    M Merad
    D V Iosifescu
    D S Charney
    J W Murrough
    Translational Psychiatry, 2017, 7 : e1065 - e1065
  • [30] KETAMINE FOR ADOLESCENT TREATMENT-RESISTANT DEPRESSION
    Cullen, Kathryn R.
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2017, 56 (10): : S345 - S345
12345